Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears
about
Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models.Co-Inflammatory Roles of TGFβ1 in the Presence of TNFα Drive a Pro-inflammatory Fate in Mesenchymal Stem CellsFactors enhancing the migration and the homing of mesenchymal stem cells in experimentally induced cardiotoxicity in rats.Cellular Therapeutics for Heart Failure: Focus on Mesenchymal Stem Cells.Mesenchymal stem cells confer resistance to doxorubicin-induced cardiac senescence by inhibiting microRNA-34a.
P2860
Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears
@ast
Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears
@en
type
label
Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears
@ast
Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears
@en
prefLabel
Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears
@ast
Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears
@en
P2093
P2860
P1476
Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears
@en
P2093
Christian Caglevic
Fernando Ezquer
Helio C Salgado
Jaime Gutiérrez
Marcelo Ezquer
Sebastián D Calligaris
P2860
P2888
P356
10.1186/S13287-015-0109-Y
P5008
P577
2015-06-24T00:00:00Z
P5875
P6179
1024002325